Contents10 sections
Thymogen is a synthetic dipeptide, glutamyl-tryptophan (Glu-Trp), that came out of Soviet research on thymus peptides. It is described as an immunomodulator: a compound meant to bring weak or overactive immune responses back toward normal, rather than simply boosting them.
In Russia, thymogen is a registered medicine given as an injection, a nasal spray or a cream, mainly for infections and recovery after illness or surgery. Elsewhere it is sold only as a research peptide.
This guide covers what thymogen is, how it is thought to work, the doses used in Russian clinical practice, what the evidence shows and how strong it is, its safety profile, and how it compares with thymalin and thymosin alpha-1.
Key Takeaways
- Thymogen (oglufanide) is a synthetic two-amino-acid peptide, Glu-Trp, developed in the Soviet Union from research on thymus extracts.
- In Russia it is a registered immunomodulator, used in short courses for infections and for recovery after illness, injury or surgery.
- Most of the clinical evidence is Russian, much of it from the peptide’s developers, and large placebo-controlled trials are lacking.
- The injectable doses used in Russian practice are small: about 50-100 mcg (micrograms) once daily for 3-10 days.
- Reported side effects are rare and mild, but long-term data are limited and thymogen is not FDA-approved. Speak with a healthcare professional before considering it.
What Is Thymogen and What Does It Do?
Thymogen (international name oglufanide) is a synthetic dipeptide made of L-glutamic acid and L-tryptophan (Glu-Trp). It was developed by the Soviet researchers Vladimir Morozov and Vladimir Khavinson, the same group behind thymalin, a peptide extract of calf thymus. Unlike larger thymic peptides such as thymosin alpha-1, thymogen is a very short molecule, and it is made as an injection, a nasal spray and a topical cream.
It is classed as an immunomodulator. The idea is that it normalises immune function: supporting responses that are weak, for example during or after an infection, a serious illness or surgery, and damping responses that are excessive. That idea comes mainly from Russian research and has not been well tested in independent trials.
At the cellular level, the research describes effects on the maturation and activity of T-lymphocytes, the white blood cells that recognise and remove infected or abnormal cells, and on cytokines, the signalling molecules that coordinate immune defence.
Thymogen belongs to the wider family of bioregulator peptides: short peptides that Russian researchers developed to act on specific tissues, in this case the thymus and the immune system.
Mechanism of Action
How thymogen works is not fully mapped. Research, much of it in cells and animals, points to several effects:
T-cell maturation and activity: Russian research reports that thymogen promotes the differentiation and maturation of T-cells, the white blood cells that coordinate immune defence and destroy infected or abnormal cells.
Cytokine regulation: Cytokines are the chemical messengers of the immune system. Thymogen is reported to move cytokine levels toward normal, raising them when the immune response is weak and lowering them when it is excessive. This is the basis for calling it an immunomodulator rather than a stimulant.
Tissue repair: Russian researchers have also reported effects on tissue repair and wound healing. This is far less studied than the immune effects.
Blood vessel growth: Under the code IM862, the same dipeptide was studied in the United States as an inhibitor of angiogenesis, the growth of new blood vessels that tumours rely on. That is how it ended up in cancer trials (see below).
Doses Used in Clinical Practice and Research
Thymogen has no approved dose outside Russia. The figures below are the doses used in Russian clinical practice (thymogen and thymalin) or commonly reported by users (BPC-157). They describe what has been used, not what anyone should take.
| Peptide | Dose used | Route | Course | Status |
|---|---|---|---|---|
| Thymogen | 50-100 mcg once daily | Intramuscular injection (also nasal spray and cream) | 3-10 days | Registered medicine in Russia; not FDA-approved |
| Thymalin | 5-20 mg (usually 10 mg) once daily | Intramuscular injection | 3-10 days | Registered medicine in Russia; not FDA-approved |
| BPC-157 | 250-500 mcg per day (commonly reported) | Oral or subcutaneous injection | No established course | Unapproved research peptide; very little human data |
Watch the units. Thymogen and BPC-157 doses are in micrograms (mcg), not milligrams (mg). One milligram is 1,000 micrograms, so mixing the two up means a 1,000-fold error. Our peptide dosage chart lists studied doses and routes for other peptides.
Health Benefits and Applications of Thymogen
Thymogen has been used clinically in Russia for decades, mainly for immune support, recovery after illness or surgery, and respiratory infections. The evidence comes mostly from Russian clinical studies, summarised in English by the peptide’s developers. In a 1997 review in the International Journal of Immunopharmacology, Morozov and Khavinson described thymalin and thymogen as treatments for immune dysfunction across a range of conditions.
Most of those studies were small, open-label and published in Russian, and they have not been confirmed by large placebo-controlled trials elsewhere. Read the benefits below with that in mind.
Immune System Support
The best-documented use is in people with weakened immunity: frequent infections, chronic illness, or immune suppression after severe illness, injury or surgery. Russian studies report that thymogen improves laboratory immune measures, such as T-cell numbers, in these patients. What is missing is evidence from large, independent, placebo-controlled trials, and there is no good evidence that it prevents infections in healthy people.
Recovery and Healing
In Russian practice, thymogen has been given alongside standard treatment after surgery, trauma and serious infections, with the aim of preventing infectious complications and shortening recovery. The reports from these settings are mostly small studies without a placebo group. There is no evidence that it speeds recovery from training or sports injuries in healthy people.
Respiratory Health
Thymogen is also used in Russia for acute respiratory infections, including as a nasal spray meant to support local immune defence in the airways. As with its other uses, the supporting studies are mainly Russian. A related bioregulator, Bronchogen, is aimed specifically at bronchial tissue.
Anti-Aging and Longevity Research
The thymus shrinks with age, and immune function declines with it, a process called immunosenescence. For that reason, thymic peptides including thymogen have been studied in gerontology research, mostly in laboratory animals. Whether thymogen slows immune ageing or extends healthy life in people has not been shown.
Cancer Research: The IM862 Trials
Outside Russia, the same molecule was developed as oglufanide (code IM862), a possible inhibitor of the blood vessel growth that tumours need. In a US phase III trial in AIDS-related Kaposi’s sarcoma, it did not outperform placebo. This is one of the few large Western trials of the compound, and it is a reminder that promising early findings do not always hold up.
Chronic Conditions and Adjunctive Therapy
In Russia, thymogen has also been used as an add-on treatment in chronic and inflammatory conditions, and it is reported to be well tolerated alongside other therapies. It is not a cure for any of these conditions. In autoimmune disease, where the immune system is already overactive, changing immune function carries its own risks (see the safety section).
Safety Profile of Thymogen
Thymogen is regarded as a low-toxicity peptide. As a dipeptide, it is expected to be broken down quickly into its two amino acids, glutamic acid and tryptophan, which are normal parts of the diet. That lowers the risk of the compound building up in the body.
Decades of use in Russia suggest it is usually well tolerated. Reported side effects are rare and mild, mostly local reactions at the injection site or brief nasal irritation with the spray. As with any peptide, allergic reactions are possible.
Long-term human safety data are limited. Thymogen is not FDA-approved, and outside Russia it is sold as a research peptide labeled not for human use, without the quality control of a licensed medicine.
Some people should avoid thymogen unless a doctor supervises its use:
- People with autoimmune disease, since changing immune function may affect disease activity.
- People on immunosuppressive drugs, for example after an organ transplant, where an immune-active compound could work against the treatment.
- Pregnant and breastfeeding women, because there are no safety data.
- Anyone with a known allergy to peptide products.
Thymogen vs. Other Peptides
Thymogen is one of several thymic peptides. The two it is most often compared with are thymalin and thymosin alpha-1. There are no head-to-head trials, so the comparisons below are based on what each compound is and how well it has been studied.
Thymogen vs. Thymalin
Thymalin is a complex of peptides extracted from calf thymus, developed by the same Russian group; thymogen is a single, synthetic dipeptide. Both are used in Russia for immune dysfunction and are given as short courses of injections. Because thymogen is one defined molecule, it is easier to standardise; thymalin is a mixture, which its developers argue gives it broader effects. Some protocols combine the two, but no trials have tested the combination.
Thymogen vs. Thymosin Alpha-1
Thymosin alpha-1 (Tα1) is a 28-amino-acid peptide that acts on dendritic cells and T-cells to support adaptive immunity. Its synthetic form, thymalfasin (Zadaxin), is approved in China and a number of other countries, mainly for chronic hepatitis B, though never by the FDA. It has been tested in far more clinical trials than thymogen, including in viral infections, sepsis and vaccine response.
Thymogen is a much smaller molecule with a mostly Russian evidence base. Of the two, Tα1 has the broader international research behind it. Our thymosin alpha-1 guide covers what those trials found.
Where to Buy Thymogen
Outside Russia, where it is a registered medicine, thymogen is not available on prescription. It is sold online as a research peptide labeled not for human use, and quality varies between vendors. Products can be underdosed, contaminated or not what the label says, and the rules on buying and owning research peptides differ by country.
Whichever vendor you look at, ask for a recent third-party certificate of analysis (COA) for the exact batch, with purity and identity testing. Our guide on how to read a peptide COA explains what to check.
Pros
- Exceptional purity & testing (≥98%)
- Pharmaceutical-style packaging for stability
- Broad catalog across peptides & nootropics
- Strong reputation & consistency across years
Cons
- Some items frequently out of stock due to high demand
- Limited long-term data for some compounds
The Bottom Line
Thymogen is a small synthetic thymic peptide with decades of clinical use in Russia, but a thin base of independent evidence.
- In Russia it is used as a short-course immunomodulator for infections and recovery after illness or surgery, at injected doses of about 50-100 mcg a day.
- The supporting studies are mostly small and Russian, and the one large US trial of the molecule, in Kaposi’s sarcoma, found no benefit over placebo.
- Reported side effects are rare and mild, but it is not FDA-approved, long-term data are limited, and research-grade products vary in quality.
Frequently Asked Questions
Disclaimer
Please read carefully
The information on this site is for educational and informational purposes only, and is not medical advice. Always consult a qualified healthcare professional before using any supplement or medication, or making changes to your health, fitness, or nutrition routine.
Not medical advice
Content here is not a substitute for professional medical advice.
Consult your doctor
Talk to your doctor before starting any supplement or new routine.
Use at your own risk
We are not responsible for adverse effects from acting on this.
Do your research
Make informed decisions about your own health.
No guarantees
Individual results vary. No claims about outcomes.
Important — Never disregard professional medical advice or delay seeking it because of something you read here. If you think you may have a medical emergency, call your doctor or your local emergency number right away.
